Does TAGRAXOFUSP Cause Capillary leak syndrome? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Capillary leak syndrome have been filed in association with TAGRAXOFUSP (Elzonris). This represents 50.0% of all adverse event reports for TAGRAXOFUSP.
12
Reports of Capillary leak syndrome with TAGRAXOFUSP
50.0%
of all TAGRAXOFUSP reports
6
Deaths
4
Hospitalizations
How Dangerous Is Capillary leak syndrome From TAGRAXOFUSP?
Of the 12 reports, 6 (50.0%) resulted in death, 4 (33.3%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Capillary leak syndrome Listed in the Official Label?
Yes, Capillary leak syndrome is listed as a known adverse reaction in the official FDA drug label for TAGRAXOFUSP.
What Other Side Effects Does TAGRAXOFUSP Cause?
What Other Drugs Cause Capillary leak syndrome?
GEMCITABINE (134)
TAGRAXOFUSP-ERZS (110)
PACLITAXEL (97)
CYCLOPHOSPHAMIDE (86)
DOCETAXEL (81)
CYTARABINE (68)
METHOTREXATE (65)
NIVOLUMAB (61)
RITUXIMAB (58)
FILGRASTIM (52)